TransMedics Share Price

TransMedics Share Price

NASDAQ: TMDX | Mid Cap | Healthcare
$85.33
-$8.70 (-9.25%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

TransMedics Stock Performance

Open
$90.97
Prev. Close
$94.03
Circuit Range
N/A
Day Range
$84.18 - $91.01
Year Range
$60.17 - $155.67
Volume
1,05,965
Average Traded
$86.21

TransMedics Share Price Today

As of 22 November 2026, TransMedics Group, Inc.'s share price is $85.33. The stock opened at $90.97, compared to its previous close of $94.03. During today's trading session, TransMedics Group, Inc.'s share price traded between $84.18 and $91.01, with an average price of $87.59. Over the past 52 weeks, the stock has recorded a high of $155.67 and a low of $60.17. In terms of performance, TransMedics Group, Inc.'s share price has risen by 27.07% over the last six months and is down 41.55% on a year-on-year basis.

TransMedics Share Price Chart

Line chart of the TransMedics price trend over the selected period. The price fell overall, ranging from 84.05 to 91.20, ending at 85.33.
$84.18$91.01
L
Show Current Price
H

TransMedics Stock Fundamentals & Key Indicators

Market Cap
$2.90B
PE Ratio (TTM)
20.50
Dividend Yield
0.00%
EPS (TTM)
$4.16
Revenue (TTM)
$605.49B
Return On Equity (TTM)
26.23%
Profit Margin
31.43%
Debt to Equity
1.56
Quarterly Earnings Growth YoY
-83.80%

TransMedics Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$160.76$173.93$189.95$203.01
Net Profit$105.38$7.32$14.68$17.07
Net Profit Margin65.55%4.21%7.73%8.41%
Income ChangeN/A-93.05%100.55%16.28%

TransMedics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$93.46$241.62$441.54$605.49
Net Profit-$36.23-$25.03$35.46$190.29
Net Profit Margin-38.77%-10.36%8.03%31.43%
Income ChangeN/A30.91%241.67%436.63%

TransMedics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets430.59306.86195.3924.85
Current Assets637.78497.22510.65252.29
Total Assets1068.37804.08706.05277.15
Non Current Liabilities505.97515.56513.9166.11
Current Liabilities89.3159.9154.9323.66
Total Liabilities595.27575.47568.8589.77
Shareholders' Equity473.1228.6137.2187.38

TransMedics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating192.8448.8-13.03-45.82
Investing-59.25-129.3-193.9554.51
Financing16.8622.87400.42167.93

About TransMedics

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

TransMedics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$66.56
$85.14
+29.12%
Oct 2026
$83.78
$65.94
-21.21%
Sep 2026
$84.72
$83.69
-8.80%
Aug 2026
$79.96
$91.77
+19.91%
Jul 2026
$69.00
$76.53
+15.27%
Jun 2026
$65.76
$66.39
-1.13%
May 2026
$99.98
$67.15
-33.32%
Apr 2026
$101.92
$100.70
+1.33%
Mar 2026
$139.50
$99.38
-31.59%
Feb 2026
$133.02
$145.27
+8.38%
Jan 2026
$124.04
$134.04
+10.15%
Dec 2025
$143.20
$121.69
-16.64%

TransMedics Share Price FAQs